COMMUNIQUÉS West-GlobeNewswire

AveXis Reports Third Quarter 2017 Financial and Operating Results
09/11/2017
– First patient has been dosed in pivotal trial of AVXS-101 for SMA Type 1 – – Conference call and webcast November 9 at 4:30 p.m. EST – CHICAGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ), a [...]
Major Shareholder Announcement
09/11/2017
Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; November 9, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announces under reference to Section 29 of the Danish Securities Trading Act [...]
Sharecare Ranked Among Fastest Growing Companies in North America on Deloitte’s 2017 Technology Fast 500™
09/11/2017
ATLANTA, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Sharecare , the digital health company that helps people manage all their health in one place, today announced it was named to Deloitte’s Technology Fast 500™, a ranking of the [...]
NANOBIOTIX : Point sur le développement global du produit NBTXR3
09/11/2017
Nanobiotix : Point sur le développement global du produit NBTXR3 Deux présentations d'Immuno-oncologie lors de la conférence Society for Immunotherapy of Cancer (SITC) en novembre ; Données de tolérance, de sécurité et [...]
NANOBIOTIX provides update on the global development of its lead product NBTXR3
09/11/2017
Nanobiotix provides update on the global development of its lead product NBTXR3 Nanobiotix will give two immuno-oncology presentations at the Society for Immunotherapy of Cancer (SITC) conference this month Tolerability [...]
Skyline Medical Inc. Signs Distribution Agreement to Market STREAMWAY System in Australia and New Zealand
09/11/2017
MINNEAPOLIS, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]
Cytori Reports Third Quarter 2017 Business and Financial Results
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Cytori Therapeutics (NASDAQ: CYTX ) (“Cytori” or the “Company”) today announced its third quarter 2017 financial results and provided updates on its corporate activity and [...]
Aileron Therapeutics Reports Third Quarter 2017 Financial Results
09/11/2017
Company continues to advance clinical trials of lead product candidate ALRN-6924 in PTCL and AML/MDS Two abstracts selected for oral presentations at American Society of Hematology Annual Meeting, highlighting potential [...]
Alphatec Holdings, Inc. Reports Third Quarter 2017 Financial Results
09/11/2017
Significant progress with transition to dedicated sales organization Continued improvement in operating expense and cash burn management CARLSBAD, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ [...]
Caladrius Biosciences Reports 2017 Third Quarter Results
09/11/2017
BASKING RIDGE, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]
Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update
09/11/2017
Announces Appointments of Michael Pehl as President and Chief Executive Officer and Brendan Delaney as Chief Commercial Officer Late-breaker Abstract on Updated Phase 2 Results of IMMU-132 in Patients with mTNBC [...]
Organovo Announces Fiscal Second-Quarter 2018 Results; Company Shifts Commercial Focus to Higher-Value Disease Modeling Opportunities and Updates Full-Year Fiscal 2018 Outlook
09/11/2017
SAN DIEGO, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ) (“Organovo”) today reported financial results for the fiscal second quarter of 2018 and updated its full-year fiscal 2018 outlook. The [...]
Immunomedics Appoints Michael Pehl President and Chief Executive Officer to Lead Next Phase of Transformative Growth
09/11/2017
MORRIS PLAINS, N.J., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU ) (“Immunomedics” or the “Company”) today announced that its Board of Directors has voted to appoint Michael Pehl as President [...]
Aclaris Therapeutics Mourns the Passing of Board Member Richard A. Bierly
09/11/2017
MALVERN, Pa., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS ), a dermatologist-led, biopharmaceutical company focused on identifying, developing and commercializing innovative and [...]
KemPharm Reports Third Quarter 2017 Results and Provides Corporate Update
09/11/2017
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Today at 4:30 p.m. ET Development & Regulatory Highlights: Filed IND for KP484, A Super-Extended Release ADHD Methylphenidate Prodrug [...]
ChromaDex Reports Third Quarter 2017 Financial Results
09/11/2017
- Company Reports Third Quarter 2017 Revenue of $6.1 Million, Up 55% Compared to Last Year - - Continued Progress on Building a Consumer Products Platform Around TRU NIAGEN ™ - IRVINE, Calif., Nov. 09, 2017 (GLOBE [...]
Dova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results
09/11/2017
NDA for avatrombopag submitted to FDA Conference call scheduled for 4:30 p.m. EST today DURHAM, N.C., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today reported its operating and [...]
ARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business Update
09/11/2017
WESTMINSTER, Colo., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO ), a biopharmaceutical company applying a precision medicine approach to developing genetically-targeted therapies for [...]
Codexis Reports Financial Results for the Third Quarter of 2017
09/11/2017
Product sales increase 71% over the prior year Affirms 2017 revenue guidance Conference call begins at 4:30 pm Eastern time today REDWOOD CITY, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS ), a [...]

Pages